Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Optogenetics Market: By Product Type, By Technique, By Application, By End User and Geography
Optogenetics Market: By Product Type, By Technique, By Application, By End User and Geography
Optogenetics Market size was valued at US$ 521.6 million in 2023 and is expected to reach US$ 652.21 million by 2030, growing at a significant CAGR of 3.9% from 2024-2030. Optogenetics is the biological technique in neuroscience used for controlling the cells in living tissue with the help of light. Optogenetics is majorly used to monitor and control the activities of neurons in living tissue. Light-sensitive proteins are used as key reagents in optogenetics. The neuronal control is achieved by using optogenetic actuators such as halorhodopsin, channelrhodopsin, and archaerhodopsin. Optical recording of the neuronal activities made with optogenetic sensors for the neurotransmitter, membrane voltage, vesicular release, or calcium. Optogenetics is adopted in ophthalmology, cardiology, behavioral science, neuroscience, and others.
The increase in the adoption of optogenetics in behavioral and neuroscience, technological advancements in optogenetics, and growth in ultrafast laser tool technology are the key factors driving the growth of the market. Moreover, the rise in the number of research laboratories adopting optogenetics technology around the globe and development in genetic engineering research is expected to propel the market over the forecast period. However, the high cost of the technology, lack of awareness about optogenetics, and the dearth of skilled professionals for optogenetic research might hamper the market over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
3.9%Largest Market
North AmericaFastest Growing Market
Europe
The global market is growing at a significant CAGR owing to rise in the adoption of optogenetics technology in neuroscience and behavioural science. An innovation of newer technologies for various diseases such as obesity and retinal diseases on optogenetics platform might fuel the market growth in near future. For instance, in August 2015, Boehringer Ingelheim and Circuit therapeutic have collaborated to develop the novel medicines for obesity on optogenetics technology platform. Acquisitions and mergers, collaborations, technological advancements, and fundraising are the strategies adopted by the companies for increasing their revenue. For instance, in November 2015, RetroSense Therapeutics secured US$ 6Mn Series B financing from various organizations for the clinical development of RST-001 for the treatment of Retinitis pigmentosa. Moreover, in November 2016, Bruker targeted the market by commercializing NeuraLight 3D an optical module for stimulating and imaging the multiple neurons.
Geographically, optogenetics market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Increase in the R&D activities in neuroscience and optogenetics and availability of professional researchers in North America is anticipated to create demand for optogenetics research in the region. Moreover, the market is developing in the Europe region owing to collaboration between the companies for developing newer technologies on optogenetics platform. However, technological developments in market, increase in the applications of optogenetics, and rise in R&D activities in Asia Pacific region plays a key role in the market growth.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 521.6 million |
|
Market Size in 2030 |
US$ 652.21 million |
|
Market CAGR |
3.9% |
|
By Product Type |
|
|
By Technique |
|
|
By Application |
|
|
By End-User |
|
|
By Region |
|
Download Free Sample Report
The global optogenetics market size was valued at US$ 521.6 million in 2023 and is projected to grow at a CAGR of 3.9% from 2024-2030.
The key segments covered in the optogenetics market are technology, components, application, and end-users.
The Optogenetics market key players are Coherent, Inc. (U.S.), Noldus Information technology (Netherlands), Thorlabs, Inc. (U.S.), Bruker (U.S.), Laserglow Technologies (Canada), Regenexbio, Inc. (U.S.), GenSight Biologics S.A. (France), Jackson Laboratory (U.S.), Applied Genetic Technologies Corporation (U.S.), Circuit Therapeutics, Inc. (U.S.)
| 1.Executive Summary |
| 2.Global Optogenetics Market Introduction |
| 2.1.Global Optogenetics Market - Taxonomy |
| 2.2.Global Optogenetics Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Technique |
| 2.2.3.Application |
| 2.2.4.End-User |
| 2.2.5.Region |
| 3.Global Optogenetics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Optogenetics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Optogenetics Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Sensors |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Actuators |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Light Equipment |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Optogenetics Market By Technique, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Viral Vectors |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Transgenic Animals |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cre-Dependant Expression System |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Optogenetics Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Neuroscience |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Behavioural science |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Cardiovascular diseases |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Retinal disease treatment |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Optogenetics Market By End-User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Pharmaceutical & Biopharmaceutical companies |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Biotechnology companies |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Academic research institutes |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Optogenetics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Optogenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Sensors |
| 10.1.2.Actuators |
| 10.1.3.Light Equipment |
| 10.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Viral Vectors |
| 10.2.2.Transgenic Animals |
| 10.2.3.Cre-Dependant Expression System |
| 10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Neuroscience |
| 10.3.2.Behavioural science |
| 10.3.3.Cardiovascular diseases |
| 10.3.4.Retinal disease treatment |
| 10.3.5.Others |
| 10.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Pharmaceutical & Biopharmaceutical companies |
| 10.4.2.Biotechnology companies |
| 10.4.3.Academic research institutes |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Optogenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Sensors |
| 11.1.2.Actuators |
| 11.1.3.Light Equipment |
| 11.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Viral Vectors |
| 11.2.2.Transgenic Animals |
| 11.2.3.Cre-Dependant Expression System |
| 11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Neuroscience |
| 11.3.2.Behavioural science |
| 11.3.3.Cardiovascular diseases |
| 11.3.4.Retinal disease treatment |
| 11.3.5.Others |
| 11.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Pharmaceutical & Biopharmaceutical companies |
| 11.4.2.Biotechnology companies |
| 11.4.3.Academic research institutes |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Optogenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Sensors |
| 12.1.2.Actuators |
| 12.1.3.Light Equipment |
| 12.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Viral Vectors |
| 12.2.2.Transgenic Animals |
| 12.2.3.Cre-Dependant Expression System |
| 12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Neuroscience |
| 12.3.2.Behavioural science |
| 12.3.3.Cardiovascular diseases |
| 12.3.4.Retinal disease treatment |
| 12.3.5.Others |
| 12.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Pharmaceutical & Biopharmaceutical companies |
| 12.4.2.Biotechnology companies |
| 12.4.3.Academic research institutes |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Optogenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Sensors |
| 13.1.2.Actuators |
| 13.1.3.Light Equipment |
| 13.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Viral Vectors |
| 13.2.2.Transgenic Animals |
| 13.2.3.Cre-Dependant Expression System |
| 13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Neuroscience |
| 13.3.2.Behavioural science |
| 13.3.3.Cardiovascular diseases |
| 13.3.4.Retinal disease treatment |
| 13.3.5.Others |
| 13.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Pharmaceutical & Biopharmaceutical companies |
| 13.4.2.Biotechnology companies |
| 13.4.3.Academic research institutes |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Optogenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Sensors |
| 14.1.2.Actuators |
| 14.1.3.Light Equipment |
| 14.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Viral Vectors |
| 14.2.2.Transgenic Animals |
| 14.2.3.Cre-Dependant Expression System |
| 14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Neuroscience |
| 14.3.2.Behavioural science |
| 14.3.3.Cardiovascular diseases |
| 14.3.4.Retinal disease treatment |
| 14.3.5.Others |
| 14.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Pharmaceutical & Biopharmaceutical companies |
| 14.4.2.Biotechnology companies |
| 14.4.3.Academic research institutes |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Coherent, Inc. (U.S) |
| 15.2.2.Noldus Information technology (Netherlands) |
| 15.2.3.Thorlabs, Inc. (U.S) |
| 15.2.4.Bruker (U.S) |
| 15.2.5.Laserglow Technologies (Canada) |
| 15.2.6.Regenexbio, Inc. (U.S) |
| 15.2.7.GenSight Biologics S.A. (France) |
| 15.2.8.Jackson Laboratory (U.S) |
| 15.2.9.Applied Genetic Technologies Corporation (U.S) |
| 15.2.10.Circuit Therapeutics, Inc. (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.